In France, menopausal hormone therapy use among women aged 45-60 is 4.4%, due to safer treatment options and concerns over health risks.
Menopause treatment use in France
In France, 4.4 percent of women aged between 45 and 60 years were taking hormonal treatment for menopause in 2025, according to an Epi-Phare study published in June 2026. Public perception of menopause treatments
The cause is the poor reputation of these medications following studies that highlighted an association between certain forms of these treatments and various health risks. French treatment differences
However, these proven risks do not apply to the treatments used in France. For example, the increased risk of breast cancer is linked to a synthetic form of progesterone that is not used in France. Safer alternatives in France
Here, the forms used in nearly all cases are either natural micronized progesterone or dydrogesterone, which do not increase this risk. Further reading
Read also Title of the link.
